• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Americas Insomnia Market

    ID: MRFR/Pharma/0126-HCR
    50 Pages
    Rahul Gotadki
    October 2025

    Americas Insomnia Market Research Report, by types of therapy (Pharmacological therapy and Non Pharmacological therapy), by drug formulation (Capsules, Tablet and others), by type of disease (poor quality of sleep, sleep maintenance and others)- Forecast till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Americas Insomnia Market Infographic
    Purchase Options

    Americas Insomnia Market Summary

    The United States insomnia market is projected to grow from 2.43 USD billion in 2024 to 4.12 USD billion by 2035.

    Key Market Trends & Highlights

    Americas Insomnia Key Trends and Highlights

    • The insomnia market in the United States is expected to experience a compound annual growth rate of 5.34 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 4.31 USD billion, indicating robust growth potential.
    • in 2024, the market is valued at 2.43 USD billion, reflecting the current demand for insomnia solutions.
    • Growing adoption of innovative sleep therapies due to increasing awareness of mental health is a major market driver.

    Market Size & Forecast

    2024 Market Size 2.43 (USD Billion)
    2035 Market Size 4.12 (USD Billion)
    CAGR (2025-2035) 4.92%

    Major Players

    Eisai, Co. (Japan), Pfizer, Inc. (US), Merck & Co Inc (US), Sanofi (France), Takeda Pharmaceutical Company (Japan), Meda Consumer Healthcare Inc (US), Pernix Therapeutics (US), Purdue Pharma L.P. (US), Consumer Healthcare Inc. (Canada), Dainippon Sumitomo (Japan), ECR Pharmaceuticals (US), Flynn Pharma (UK), Johnson & Johnson (US), Astellas (UK), Biocodex S A (France), Neurim (Switzerland), SkyePharma (UK), Vanda Pharmaceuticals Inc. (US)

    Key Companies in the Americas Insomnia Market market include

    Report Scope

    Attribute/Metric Details
    Market Size 2024 USD 2.43 billion
    Market Size 2035 4.12 (Value (USD Billion))
    Compound Annual Growth Rate (CAGR) 4.92% (2025 - 2035)
    Base Year 2024
    Market Forecast Period 2025 - 2035
    Historical Data 2019- 2021
    Market Forecast Units Value (USD Billion)
    Report Coverage Revenue Forecast, Growth Factors, Market Competitive Landscape, and Trends
    Segments Covered Types Of Therapy, Drug Formulation, Type Of Diseases Condition and Region
    Geographies Covered North America
    Countries Covered U.S, Canada
    Key Companies Profiled Eisai, Co. (Japan), Pfizer, Inc. (US), Merck & Co Inc (US), Sanofi (France), Takeda Pharmaceutical Company (Japan),  Meda Consumer Healthcare Inc (US), Pernix Therapeutics (US), Purdue Pharma L.P. (US), Consumer Healthcare Inc. (Canada), Dainippon Sumitomo (Japan), ECR Pharmaceuticals (US), Flynn Pharma (UK), Johnson & Johnson (US),  Astellas (UK), Biocodex S A (France), Neurim (Switzerland), SkyePharma (UK), and Vanda Pharmaceuticals Inc. (US). 
    Key Market Opportunities Increasing awareness of sleep disorders, and changing lifestyle patterns
    Key Market Dynamics Increasing prevalence of insomnia among the population
    Market Size 2025 2.55 (Value (USD Billion))

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Leave a Comment
    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials